WallStreetZenWallStreetZen

NYSE: GSK
GSK PLC Earnings & Revenue

GSK past earnings growth

How has GSK's earnings growth performed historically?
Company
-7.13%
Industry
98.03%
Market
93.85%
GSK's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GSK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
GSK's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

GSK past revenue growth

How has GSK's revenue growth performed historically?
Company
8.05%
Industry
24.73%
Market
51.24%
GSK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GSK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GSK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GSK earnings and revenue history

Current Revenue
$48.0B
Current Earnings
$6.7B
Current Profit Margin
14%
GSK's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

GSK Return on Equity

Current Company
33%
Current Industry
42%
Current Market
38.4%
GSK's Return on Equity (33%)... subscribe to Premium to read more.
High Return on Equity Performance

GSK Return on Assets

Current Company
6.3%
Current Industry
10.4%
GSK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GSK Return on Capital Employed

Current Company
9.83%
Current Industry
15.6%
GSK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GSK vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GSK$45.60B$11.44B$6.39B+5.77%+25.68%
AMGN$26.32B$11.12B$5.72B+2.79%-0.84%
SNY$44.52B$13.07B$7.07B+4.04%+7.95%
GILD$27.47B$8.97B$4.52B-1.15%-17.76%
BMY$46.96B$17.84B$6.25B+18.66%-0.49%

GSK Earnings & Revenue FAQ

What were GSK's earnings last quarter?

GSK (NYSE: GSK) reported Q1 2022 earnings per share (EPS) of $0.95, up 60.44% year over year. Total GSK earnings for the quarter were $2.37 billion. In the same quarter last year, GSK's earnings per share (EPS) was $0.59.

What was GSK's earnings growth in the past year?

As of Q2 2022, GSK's earnings has grown -7.13% year over year. This is 105.16 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 98.03%. GSK's earnings in the past year totalled $6.39 billion.

What was GSK's revenue last quarter?

GSK (NYSE: GSK) reported Q1 2022 revenue of $12.87 billion up 26.64% year over year. In the same quarter last year, GSK's revenue was $10.16 billion.

What was GSK's revenue growth in the past year?

As of Q2 2022, GSK's revenue has grown 8.05% year over year. This is 16.68 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 24.73%. GSK's revenue in the past year totalled $45.60 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.